Blog - etira

Breakthroughs that
make news.

See news releases about Etira, our stellar team,
our breakthrough innovations and our relentless steps to improve the survival of patients with advanced cancers.

ERX-315 SUBMITTED FOR HREC APPROVAL

Dallas, TX – May 14th, 2024: Etira is pleased to announce the submission of the regulatory documents for approval of administration of its breakthrough oncology drug ERX-315 to the Human Research Ethics Committee (HREC) in Australia. This…

ERX-208 potency in Ovarian Cancer

News

San Diego, CA. April 10, 2024: Etira founder Dr Ratna Vadlamudi’s laboratory presents comprehensive data on the activity of ERX-208 in ovarian cancer. ERX-208 is active against all four molecular subtypes of ovarian cancer and its activity…

Targeting LIPA in ovarian cancer

News

Dallas, TX. January 24, 2024: We are pleased to present a manuscript in Cancers from the laboratory of Etira founder Dr. Ratna Vadlamudi. The data presented show that ERX-41 targets LIPA in ovarian cancer and is effective against all 4 subtypes…

ERX-315 introduced at SABCS 2023

News

San Antonio, TX. December 7, 2023: Etira is pleased to present the data with its lead compound ERX-315 that cause catastrophic levels of ER stress, resulting in breast cancer cell death, and that can successfully function against multiple…

Independent validation of LIPA as a molecular target in TNBC

News

Dallas, TX. October 2, 2023: Etira is pleased to note the independent validation of LIPA as a molecular target in TNBC in a preprint in biorxiv from Dr. Esser’s group in Dusseldorf, Germany. The authors conclude that LIPA-activity is a novel…

One year later, highest almetric score for any paper published in Nature Cancer!

News

Dallas, Texas. June 1, 2023: One year after its online publication, we are pleased to note that our manuscript titled “Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid…

Breakthroughs thatmake news.

See news releases about Etira, our stellar team,our breakthrough innovations and our relentless steps to improve the survival of patients with advanced cancers.

Where to find us

Breakthroughs that
make news.

See news releases about Etira, our stellar team,
our breakthrough innovations and our relentless steps to improve the survival of patients with advanced cancers.